What are the antiviral treatment options for hepatitis C?

Antiviral treatment is indispensable for diseases such as hepatitis C, because antiviral treatment can be said to be the most scientific and effective method at present, and the use of antiviral drugs must be paid attention to, including protein drugs interferon and nucleoside drugs.

1. Protein-based interferon: Most protein-based antiviral drugs are inherent immune proteins in the human body produced by recombinant DNA. Among them, α-interferon is the earliest and most widely used one on the market. Interferon is the only protein-based antiviral drug currently approved for the treatment of hepatitis C. my country started producing interferon in 1995, and the development momentum has been very rapid. Currently, the country has an annual production capacity of 25 million units, of which 50% is used to treat hepatitis B and hepatitis C.

2. Nucleoside drugs: Representative varieties of this type of drugs are ribavirin (ribavirin), acyclovir (acyclovir) and ganciclovir. Among them, ribavirin, as an old nucleoside product, has a strong blocking effect on the replication of hepatitis C virus. In particular, the new discovery that the efficacy of using ribavirin in combination with α-2b interferon can be more than doubled compared to using interferon alone has led to a surge in the sales of ribavirin.

3. It is worth noting that for a single antiviral drug. This type of drug cannot be discontinued easily, and relapse is likely to occur after discontinuation. In addition, if the drug is purchased on your own, abuse of the drug can lead to viral mutation and drug resistance in a short period of time; as for a single interferon drug. Whether it is ordinary interferon or long-acting interferon, certain adverse reactions will occur during use, and some patients will develop drug-resistant lesions, and the condition is prone to rebound once the drug is stopped. Such a single therapy is difficult to cure hepatitis C fundamentally. The world's most cutting-edge diagnostic and treatment technology, "911 Biological Vaccine Therapy", is a new diagnostic and treatment model tailored for hepatitis C patients based on their condition.

4. In short, there is a biggest problem with both hepatitis B and hepatitis C. Although the replication of hepatitis C virus will be reduced and liver inflammation will be gradually controlled after antiviral treatment, the virus will mutate during long-term medication, which will aggravate the disease or cause other complications. It is recommended that patients still go to a liver disease hospital regularly for relevant examinations, follow the guidance of experts, and treat hepatitis C in a way that suits them.